Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2014
10/09/2014US20140302103 Hair care composition comprising a pre-emulsified formulation
10/09/2014US20140302090 Novel vaccine
10/09/2014US20140302051 Biocompatible Hydrogel Polymer Formulations for the Controlled Delivery of Biomolecules
10/09/2014US20140302007 Botulinum toxin formulation
10/09/2014US20140302000 Pharmaceutical compositions of lipase-containing products, in particular of pancreatin
10/09/2014US20140301998 Preparation containing diol
10/09/2014US20140301954 Mucous membrane active agent application
10/09/2014US20140301951 Porous nanoparticle supported lipid nanostructures
10/09/2014US20140300025 Oral disintegrating tablet
10/08/2014EP2787050A1 Lecithin-organogel-forming agent
10/08/2014EP2786760A1 Antiviral agent
10/08/2014EP2786752A1 Ropinirole-containing adhesive patch
10/08/2014EP2786748A1 Transdermal therapeutic system comprising rivastigmine
10/08/2014EP2786747A1 Promoting hair growth solution containing chlorine dioxide preparation method and use method thereof
10/08/2014EP2786746A1 Stabilizing a Liquid Formulation Containing a Protein Drug
10/08/2014EP2785838A2 Targeted lysosomal enzyme compounds
10/08/2014EP2785837A2 Targeted enzyme compounds and uses thereof
10/08/2014EP2785340A1 Compositions and methods for treating hepatitis c virus
10/08/2014EP2785337A1 Acamprosate formulations, methods of using the same, and combinations comprising the same
10/08/2014EP2785334A1 Transdermal therapeutic system for administering fentanyl or an analogue thereof
10/08/2014EP2785333A1 Amphipathic lipid-based sustained release compositions
10/08/2014EP2785332A1 A process for the preparation of solid dispersion of lopinavir and ritonavir
10/08/2014EP2785331A1 Dry coated tablet
10/08/2014EP2785330A2 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
10/08/2014EP2785329A1 Method of neutralizing an aerosol containing a compound of interest dissolved in a low ph solution
10/08/2014EP2785328A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine
10/08/2014EP2785327A1 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
10/08/2014EP2785326A2 Geometrically engineered particles and methods for modulating macrophage or immune responses
10/08/2014EP2785325A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
10/08/2014EP2785324A1 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
10/08/2014EP2785322A1 Jojoba extract useful in improving skin barrier functions
10/08/2014EP2785292A1 Coated condom
10/07/2014US8854617 Compounds and markers for surface-enhanced Raman scattering
10/07/2014US8853423 Indane estrogen receptor modulators and uses thereof
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853377 mRNA for use in treatment of human genetic diseases
10/07/2014US8853268 Ophthalmic solution
10/07/2014US8853265 Oral composition to reduce cold symptoms and duration of same
10/07/2014US8853264 Use of lignan compounds for treating or preventing inflammatory disease
10/07/2014US8853262 pKa buffered vitamin C composition and method
10/07/2014US8853257 Succinimide derivatives as ocular hypotensive agents
10/07/2014US8853245 Orally bioavailable dabigatran prodrugs for the treatment of diseases
10/07/2014US8853223 Therapeutic composition to treat lesions caused by herpes simplex virus
10/07/2014US8853195 Composition for reducing the exudation of serum proteins
10/07/2014US8853187 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
10/07/2014US8853184 Polysaccharide gel formulation having increased longevity
10/07/2014US8853170 Compositions comprising sugar-cysteine products
10/07/2014US8853162 Interpenetrating polymer network comprising fibrin
10/07/2014US8852648 Delivery of biologically-active agents using volatile, hydrophobic solvents
10/07/2014US8852646 Particulate implants and biodegradable fiducial markers
10/07/2014US8852645 Self-assembled toroidal-spiral particles and manufacture and uses thereof
10/07/2014US8852644 Method and device for producing microparticles or nanoparticles
10/07/2014US8852643 Liquid cleaning and/or cleansing composition
10/07/2014US8852642 Glyphosate formulation
10/07/2014US8852641 Polymer microgel beads and preparative method thereof
10/07/2014US8852640 Micelles for delivery of nitric oxide
10/07/2014US8852639 Antimicrobial foam and method of manufacture
10/07/2014US8852638 Sustained release small molecule drug formulation
10/07/2014US8852637 Extracellular matrix compositions for the treatment of cancer
10/07/2014US8852636 Pharmaceutical compositions for the coordinated delivery of NSAIDs
10/07/2014US8852635 Pharmaceutical compositions of fenofibrate
10/07/2014US8852634 Dosage formulation
10/07/2014US8852633 Orodispersible domperidone tablets
10/07/2014US8852632 Pharmaceutical formulation containing a release rate controlling composition
10/07/2014US8852631 Acid resistant capsules
10/07/2014US8852630 Chimeric small molecules for the recruitment of antibodies to cancer cells
10/07/2014US8852629 Drug delivery system for hydrophobic drugs
10/07/2014US8852628 Transdermal drug delivery system for diclofenac
10/07/2014US8852626 Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
10/07/2014US8852624 Biomedical implants comprising surface-modified ceramic particles and biodegradable stereo complex polymers, its use for suppressing inflammation and improvement of mechanical property, and preparation method thereof
10/07/2014US8852623 Implantable polymeric device for sustained release of dopamine agonist
10/07/2014US8852616 Cosmetic compositions with near infra-red (NIR) light-emitting material and methods therefor
10/07/2014US8852614 Hydrogels with network defects enhanced by nanoparticle incorporation
10/07/2014US8852607 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/07/2014US8852566 Compositions and methods for preferential distribution of active agents to injury sites
10/07/2014US8852558 In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
10/07/2014US8852557 Aerosols for sinunasal drug delivery
10/07/2014US8852447 Porous nanostructures and methods involving the same
10/07/2014US8852224 Therapeutic delivery system
10/07/2014US8852173 Methods and systems for providing therapies into the pericardial space
10/07/2014US8852160 Venous access port with molded and/or radiopaque indicia
10/07/2014US8852151 Swallowable drug delivery device and method of delivery
10/02/2014WO2014160989A2 Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
10/02/2014WO2014160828A1 Bimatoprost ocular silicone inserts and methods of use thereof
10/02/2014WO2014160729A1 Composition and method for treating cancer
10/02/2014WO2014160633A1 Pharmaceutical compositions of dimethyl fumarate
10/02/2014WO2014160628A2 Articles and methods for preventing and treating dermatologic adverse events
10/02/2014WO2014160465A2 Immune-modifying particles for the treatment of inflammation
10/02/2014WO2014160404A1 Improved oral drug devices and drug formulations
10/02/2014WO2014160392A1 Modified docetaxel liposome formulations
10/02/2014WO2014160387A2 Compositions, methods and devices for local drug delivery
10/02/2014WO2014160377A1 Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use
10/02/2014WO2014160371A1 Chimeric cytokine formulations for ocular delivery
10/02/2014WO2014160339A1 Compounds for treating inflammatory and hyperproliferative diseases
10/02/2014WO2014160337A1 Liposomal cisplatin compositions for cancer therapy
10/02/2014WO2014160279A1 Stabilized cream formulations comprising sandalwood oil
10/02/2014WO2014160187A1 Cardiovascular disease treatment and prevention
10/02/2014WO2014160167A1 Implantable drug delivery compositions comprising aromatic polyurethanes and methods of treatment thereof
10/02/2014WO2014160155A2 Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof
10/02/2014WO2014160102A1 Brain and neural treatments comprising peptides and other compositions
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 2991